Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.91% | 5.43% | 27.20% | -27.41% | -18.89% |
| Total Depreciation and Amortization | -0.56% | -0.57% | -1.58% | -25.28% | -43.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.26% | -40.51% | -93.94% | 189.25% | 127.61% |
| Change in Net Operating Assets | -302.93% | -136.44% | -28.47% | 36.67% | 67.65% |
| Cash from Operations | -17.70% | -8.85% | -4.84% | -5.31% | 1.06% |
| Capital Expenditure | 24.94% | 16.45% | 9.38% | 33.45% | -91.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 24.94% | 56.67% | 54.56% | 69.50% | 27.94% |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | -98.33% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.63% | 56.44% | 223.59% | 12,908.65% | 12,908.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.80% | -1.05% | 8.67% | 22.34% | 118.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.33% | -63.23% | 462.47% | 256.64% | 443.51% |